Search

everythinglearnresearchcommunity

for

Search:↓

Men with androgenetic alopecia may have higher cholesterol and triglycerides.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Polycystic ovary syndrome causes chronic inflammation affecting all body systems, but proper nutrition, exercise, and supplements can improve the condition.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Women with PCOS have higher cardiometabolic risks.

High testosterone increases heart disease risk in women with PCOS.

Premature hair greying may indicate a higher risk of metabolic problems.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Physical activity, height, and smoking affect prostate cancer risk.

Age, stress, and anger increase the risk of hair fall.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.